[Clinical efficacy and reduction effect on prostatic volume of chlormadinone acetate combined with tamsulosin hydrochloride in benign prostatic hyperplasia patients insufficiently treated with tamsulosin hydrochloride only].

@article{Ueki1998ClinicalEA,
  title={[Clinical efficacy and reduction effect on prostatic volume of chlormadinone acetate combined with tamsulosin hydrochloride in benign prostatic hyperplasia patients insufficiently treated with tamsulosin hydrochloride only].},
  author={Osamu Ueki and Kouhei Kawaguchi and Tetsuo Katsumi and Kazuhiko Murayama and Kunihiko Kameda and Akio Nishino and Akihiko Sakai and T Haginaka and Kazunori Miyazaki and Toyoki Asari and Masayuki Egawa},
  journal={Hinyokika kiyo. Acta urologica Japonica},
  year={1998},
  volume={44 8},
  pages={
          565-73
        }
}
Alpha adrenergic blocker has become the first choice in the medical treatment of benign prostatic hyperplasia (BPH). The efficacy of alpha adrenergic blocker has been suggested to be related to the prostatic tissue components, and to be ineffective in treating the clinical symptoms caused by BPH in some cases. The efficacy and prostate reduction of an anti-androgenic agent, chlormadinone acetate, combined with alpha adrenergic blocker, tamsulosin hydrochloride, were evaluated using 40-BPH… CONTINUE READING